Table 1.
Analysis | Full-heritage Pima Indians | Non-full-heritage Pima Indiansb |
---|---|---|
Lipid analysis (n=5,494)a | ||
n (% IFGc) | 2,717 (10.4) | 2,777 (10.8) |
Age, yearsd | 41.4±15.2 | 30.7±12.9 |
Age range, years | 15.0–90.4 | 15.0–87.9 |
TC, mmol/l | 4.58±1.01 | 4.57±0.98 |
HDL-C, mmol/l | 1.12±0.36 | 1.20±0.35 |
LDL-C, mmol/l | 2.63±0.79 | 2.69±0.82 |
TG, mmol/l | 1.64±1.28 | 1.54±1.24 |
Type 2 diabetes analysis (N=7,710)e with/without diabetes |
||
n (% age <15 years) | 1,684 (0.77) / 1,941 (9.8) | 865 (2.5) / 3,220 (19.5) |
Female sex, % | 63 / 52 | 59 / 53 |
Age, yearsd | 49.1±14.0 / 32.1±14.6 | 41.2 ± 14.1 / 24.9 ± 11.9 |
Age range, years | 10.6–90.4 / 5.6–85.3 | 9.4–85.4 / 5.3–87.9 |
Type 2 diabetes analysis set restricted to individuals with HDL- C data (n=5,494) with/without diabetes |
||
n | 1,325 / 1,392 | 653 / 2,124 |
Female sex, % | 64.7 / 53.5 | 60.5 / 56.5 |
Age, yearsd | 48.7±13.6 / 34.5±13.2 | 41.1±13.2 / 27.6±11.03 |
Age range, years | 15.5–90.4 / 15.0–81.7 | 15.2–85.3 / 15.0–87.9 |
HOMA analysis (n=5,429)f | ||
n (% IFGc) | 2,542 (35) | 2,887 (22.9) |
Age, yearsd | 39±14.5 | 30.4±12.3 |
Age range, years | 15.0–85.3 | 6.5–87.9 |
HOMA-IR, SD unitsg | −0.09±0.8 | −0.30±0.9 |
HOMA-B, SD unitsg | 0.34±0.7 | 0.25±0.7 |
Data are presented as means ± SD unless stated otherwise
Data used from last examination before the year 2005
Heritage is, on average, 4/8 Pima and an additional 2/8 American Indian of different tribes
IFG is based on the 2005 ADA criteria
Age reported is the age at last examination for the trait reported
These individuals constituted 4,625 sibships of which 68% are singletons
Data from the last visit when the participant was non-diabetic. Data from individuals who were diabetic during the first visit were not included
Three different assays for serum insulin were used over the course of the longitudinal study; to account for differing sensitivities among these assays, the natural logarithms of the HOMA values for all examinations were standardised within assay prior to analysis, and results reported in SD units
IFG, impaired fasting glucose